Literature DB >> 8631809

Activation of nuclear factor of activated T cells in a cyclosporin A-resistant pathway.

P Ghosh1, A Sica, M Cippitelli, J Subleski, R Lahesmaa, H A Young, N R Rice.   

Abstract

The mechanism of action of the immunosuppressive drug cyclosporin A (CsA) is the inactivation of the Ca2+/calmodulin-dependent serine-threonine phosphatase calcineurin by the drug-immunophilin complex. Inactive calcineurin is unable to activate the nuclear factor of activated T cells (NFAT), a transcription factor required for expression of the interleukin 2 (IL-2) gene. IL-2 production by CsA-treated cells is therefore dramatically reduced. We demonstrate here, however, that NFAT can be activated, and significant levels of IL-2 can be produced by the CsA-resistant CD28-signaling pathway. In transient transfection assays, both multicopy NFAT- and IL-2 promoter-beta-galactosidase reporter gene constructs could be activated by phorbol 12-myristate 13-acetate (PMA)/alpha-CD28 stimulation, and this activation was resistant to CsA. Electrophoretic mobility shift assay showed the induction of a CsA-resistant NFAT complex in the nuclear extracts of peripheral blood T cells stimulated with PMA plus alphaCD28. Peripheral blood T cells stimulated with PMA/alphaCD28 produced IL-2 in the presence of CsA. Collectively, these data suggest that NFAT can be activated and IL-2 can be produced in a calcineurin independent manner.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631809     DOI: 10.1074/jbc.271.13.7700

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

2.  Multiple cytokines sharing the common receptor gamma chain can induce CD154/CD40 ligand expression by human CD4+ T lymphocytes via a cyclosporin A-resistant pathway.

Authors:  J D Fayen
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

3.  Expression of NFAT-family proteins in normal human T cells.

Authors:  L Lyakh; P Ghosh; N R Rice
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

4.  Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors.

Authors:  S B Maggirwar; E W Harhaj; S C Sun
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

5.  The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway.

Authors:  E Lara-Pezzi; A L Armesilla; P L Majano; J M Redondo; M López-Cabrera
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

6.  Cholecystokinin activates pancreatic calcineurin-NFAT signaling in vitro and in vivo.

Authors:  Grzegorz T Gurda; LiLi Guo; Sae-Hong Lee; Jeffery D Molkentin; John A Williams
Journal:  Mol Biol Cell       Date:  2007-10-31       Impact factor: 4.138

7.  Utilization of an NF-ATp binding promoter element for EGR3 expression in T cells but not fibroblasts provides a molecular model for the lymphoid cell-specific effect of cyclosporin A.

Authors:  H W Mages; R Baag; B Steiner; R A Kroczek
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

8.  The effects of Cyclosporine A and azathioprine on human T cells activated by different costimulatory signals.

Authors:  Judith Leitner; Karin Drobits; Winfried F Pickl; Otto Majdic; Gerhard Zlabinger; Peter Steinberger
Journal:  Immunol Lett       Date:  2011-07-02       Impact factor: 3.685

9.  Calcineurin B in CD4+ T Cells Prevents Autoimmune Colitis by Negatively Regulating the JAK/STAT Pathway.

Authors:  Andrea Mencarelli; Maurizio Vacca; Hanif Javanmard Khameneh; Enzo Acerbi; Alicia Tay; Francesca Zolezzi; Michael Poidinger; Alessandra Mortellaro
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

10.  A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).

Authors:  Yohsuke Harada; Daisuke Ohgai; Ryosuke Watanabe; Kazuhiro Okano; Osamu Koiwai; Kazunari Tanabe; Hiroshi Toma; Amnon Altman; Ryo Abe
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.